Aroxybutynin and atomoxetine (AD109) for obstructive sleep apnea: a randomized phase 3 trial (SynAIRgy) | American Journal of Respiratory and Critical Care Medicine | Oxford Academic

At a Glance Commentary. Atomoxetine Aroxybutynin Scientific Knowledge on the Subject: AD109 (aroxybutynin 2.5 mg/atomoxetine 75 mg), an inve...